Kolonko, A.; Słabiak-Błaż, N.; Karkoszka, H.; Więcek, A.; Piecha, G.
The Preliminary Results of Bortezomib Used as A Primary Treatment for An Early Acute Antibody-Mediated Rejection after Kidney Transplantation—A Single-Center Case Series. J. Clin. Med. 2020, 9, 529.
https://doi.org/10.3390/jcm9020529
AMA Style
Kolonko A, Słabiak-Błaż N, Karkoszka H, Więcek A, Piecha G.
The Preliminary Results of Bortezomib Used as A Primary Treatment for An Early Acute Antibody-Mediated Rejection after Kidney Transplantation—A Single-Center Case Series. Journal of Clinical Medicine. 2020; 9(2):529.
https://doi.org/10.3390/jcm9020529
Chicago/Turabian Style
Kolonko, Aureliusz, Natalia Słabiak-Błaż, Henryk Karkoszka, Andrzej Więcek, and Grzegorz Piecha.
2020. "The Preliminary Results of Bortezomib Used as A Primary Treatment for An Early Acute Antibody-Mediated Rejection after Kidney Transplantation—A Single-Center Case Series" Journal of Clinical Medicine 9, no. 2: 529.
https://doi.org/10.3390/jcm9020529
APA Style
Kolonko, A., Słabiak-Błaż, N., Karkoszka, H., Więcek, A., & Piecha, G.
(2020). The Preliminary Results of Bortezomib Used as A Primary Treatment for An Early Acute Antibody-Mediated Rejection after Kidney Transplantation—A Single-Center Case Series. Journal of Clinical Medicine, 9(2), 529.
https://doi.org/10.3390/jcm9020529